Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and acute pulmonary hypertension post cardiopulmonary bypass in children with congenital cardiac diseases

Cardiology in the Young

Volumn 21, Issue 2, 2011, Pages 161-169

  Loukanov, Tsvetomir ^a   Hoss, Katharina ^a   Tonchev, Pentcho ^b   Klimpel, Homa ^a   Arnold, Raul ^a   Sebening, Christian ^a   Karck, Matthias ^a   Gorenflo, Matthias ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Cardiac surgery; post operative complications; prognostic factors

Indexed keywords

ACUTE DISEASE; ACUTE PULMONARY HYPERTENSION; ADOLESCENT; ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CONTROLLED STUDY; CYANOTIC HEART DISEASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART LEFT RIGHT SHUNT; HUMAN; INFANT; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MEAN ARTERIAL PRESSURE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; ENZYMOLOGY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; MALE; METABOLISM; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ACUTE DISEASE; ADOLESCENT; ADULT; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79960149976     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951110001630     Document Type: Article

References (41)

1. Lindberg L, Olsson AK, Jogi P, et al. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 2002; 123: 1155-1163.
2. Bando K, Turrentine MW, Sharp TG, et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management. J Thorac Cardiovasc Surg 1996; 112: 1600-1607; discussion 1607-1609.
3. Miller OI, Tang SF, Keech A, et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000; 356: 1464-1469.
4. Palmer RMJ, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Comm 1988; 153: 1251-1256.
5. Droma Y, Hanaoka M, Ota M, et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 2002; 106: 826-830.
6. Ahsan A, Mohd G, Norboo T, Baig MA, Qadar Pasha MA. Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema. Chest 2006; 130: 1511-1519. (Pubitemid 44786747)
7. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16: 31-35. (Pubitemid 28069817)
8. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-69. (Pubitemid 28398388)
9. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-1510. (Pubitemid 28273291)
10. Hingorani AD, Liang CF, Fatibene J, et al. A common variant of the endothelial nitric oxide synthase (Glu298-.Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 1515-1520. (Pubitemid 29461463)
11. Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488. (Pubitemid 23236991)
12. Tanus-Santos JE, Desai M, Flockhart DA, et al. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Phrmacogenetics 2001; 11: 719-725. (Pubitemid 33078242)
13. Galié N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-2278.
14. Wilkinson JL. Haemodynamic calculations in the catheter laboratory. Heart 2001; 85: 113-120. (Pubitemid 32973422)
15. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci 2000; 66: 2557-2562. (Pubitemid 30327470)
16. Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8. (Pubitemid 28324117)
17. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997; 53: 1253-1261. (Pubitemid 28013569)
18. Storm TM, Wienker TF. DeFinetti Program. . helmholtz-muenchen.de/cgi-bin/ hw/hwa1.pl. 2005
19. Sackett DL, Richardson WS, RosenbergW, Haynes RB. Evidence -Based Medicine. How to Practice Teach EBM. Churchill Livingstone, New York, 1997.
20. Godfrey V, Chan SL, Cassidy A, et al. The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers. Cardiovasc Drug Rev 2007; 25: 280-288. (Pubitemid 47547463)
21. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 2000; 97: 2832-2835. (Pubitemid 30159257)
22. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)-.Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 2001; 276: 26674-26679.
23. Golser R, Gorren AC, Mayer B, Schmidt K. Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric Oxide 2003; 8: 7-14. (Pubitemid 36263427)
24. McDonald DM, Alp NJ, Channon KM. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 2004; 14: 831-839. (Pubitemid 40054338)
25. Hibi K, Ishigami T, Tamura K, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32: 521-526. (Pubitemid 28429143)
26. Shimasaki Y, Yasue H, Yoshimura M, et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 1998; 31: 1506-1510. (Pubitemid 28273291)
27. Cai H,Wang X, Colagiuri S,Wilcken DE. A common Glu298-.Asp (894G-.T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care 1998; 21: 2195-2196. (Pubitemid 28549178)
28. Cai H,Wilcken DE,Wang XL. The Glu-298-.Asp (894G-.T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 1999; 77: 511-514. (Pubitemid 29372583)
29. Liyou N, Simons L, Friedlander Y, et al. Coronary artery disease is not associated with the E298-.D variant of the constitutive, endothelial nitric oxide synthase gene. Clin Genet 1998; 54: 528-529. (Pubitemid 29002419)
30. Poirier O, Mao C, Mallet C, et al. Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 1999; 29: 284-290. (Pubitemid 29188821)
31. Yoshimura M, Yasue H, Nakayama M, et al. Genetic risk factors for coronary artery spasm: significance of endothelial nitric oxide synthase gene T-786-.C and missense Glu298Asp variants. J Investig Med 2000; 48: 367-374.
32. Lacolley P, Gautier S, Poirier O, et al. Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998; 16: 31-35. (Pubitemid 28069817)
33. Benjafield AV, Morris BJ. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am J Hypertens 2000; 13: 994-998.
34. Kato N, Sugiyama T, Morita H, et al. Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999; 33: 933-936. (Pubitemid 29186387)
35. Lee YC, Huang CH, Wang CJ, et al. The associations among eNOS G894T gene polymorphism, erectile dysfunction and related risk factors. BJU Int 2007; 100: 1116-1120.
36. Rosas-Vargas H, Coral-Vazquez RM, Tapia R, et al. Glu298Asp endothelial nitric oxide synthase polymorphism is a risk factor for erectile dysfunction in the Mexican Mestizo population. J Androl 2004; 25: 728-732. (Pubitemid 39096306)
37. Eisenhardt A, Sperling H, Hauck E, et al. ACE gene I/D and NOS3 G894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology 2003; 62: 152-157. (Pubitemid 36802105)
38. Li M, Stenmark KR, Shandas R, Tan W. Effects of pathological flow on pulmonary artery endothelial production of vasoactive mediators and growth factors. J Vasc Res 2009; 46: 561-571.
39. Sud N, Sharma S, Wiseman DA, et al. Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 2007; 293: L1444-L1453. (Pubitemid 350255027)
40. Sharma S, Kumar S, Sud N, et al. Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow. Vascul Pharmacol 2009; 51: 359-364.
41. Lopes AA, Rabinovitch M, Chang A, et al. Statements on the Management of Pulmonary Hypertension Associated with Congenital Heart Disease. Cardiology in the Young 2009; 19 E-suppl.1: 1-53.